Company Data
IN8bio Inc.
Ticker
INAB
Current Price
$2.21 -2.21%
Market Cap
$10.0M
Price Target
Refer to Report
Volume
19.3K
52wk Range
$1.98 - $16.86
Overview
IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.